GPPR Podcast Editor Joe Lustig (MPP-EP ’24) speaks with Dr. Richard Frank – a distinguished health economist, Brookings Institution fellow, and Director of the Schaeffer Initiative for Health Policy – to talk about why drug prices are so high, the steps Congress has taken to bring them down, and what they might do next. Check […]
Prescription Drug Pricing: Understanding the Complexities of Patents and Market Exclusivity
By this point we’ve all heard about the rising cost of prescription drugs; last month we ran an introduction to this series explaining just that. But what’s the real story behind the trend? Is it simply greedy CEOs hoping to rake in more profits and garner more investor speculation, or is the reality more complicated? […]